Impact of diabetes on CNS: Role of signal transduction cascade

Brain Research Bulletin

Volumn 49, Issue 3, 1999, Pages 155-162

  Bhardwaj, Sanjeev Kumar ^a   Sandhu, Sukhjit Kaur ^a   Sharma, Poonam ^a   Kaur, Gurcharan ^a  

^a GURU NANAK DEV UNIVERSITY   (India)

Author keywords

CNS; Diabetic neuropathy; Protein kinases; Signal transduction cascade

Indexed keywords

BRAIN PROTEIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIACYLGLYCEROL; GLUCOSE; INOSITOL PHOSPHATE; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PROTEIN KINASE; PROTEIN KINASE C; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; GLUCOSE BLOOD LEVEL; MALE; NEUROPATHOLOGY; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BLOOD GLUCOSE; BRAIN; CENTRAL NERVOUS SYSTEM; CYCLIC AMP; DIABETES MELLITUS, EXPERIMENTAL; DIGLYCERIDES; HYPERGLYCEMIA; INOSITOL PHOSPHATES; MALE; NERVE TISSUE PROTEINS; PHOSPHOLIPASES; PROTEIN KINASES; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS;

EID: 0033049924     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(99)00047-7     Document Type: Article

References (48)

1. +-ATPase is an effector protein for protein kinase C in renal proximal tubule cells. Am. J. Physiol. 256:1989;F370-F373.
2. Biro K., Jednakovits A., Kukorelli T., Hegedus E., Koranyi L. Bimoclomol (BRLP-42) ameliorates peripheral neuropathy in streptozotocin in duced diabetic rats. Brain Res. Bull. 44:1997;259-263.
3. Butcher R.W., Ho R.J., Meng H.C., Sutherland E.W. Adenosine-3′,5′-monophosphatein biological materials, II The measurement of adenosine-3′,5′-monophosphate in tissues and the role of the cyclic nucleotide in the lipolytic response of fat to epinepherine . J. Biol. Chem. 240:1965;4515-4523.
4. Calcutt N.A., Mizisin A.P., Kalichman N.W. Aldose reductase inhibition. Doppler flux and conduction in diabetic rat nerve. Eur. J. Pharmacol. 251:1994;27-33.
5. Carpentier G., Behue N., Fournier F. Phospholipase C activates protein kinase C during induction of slow Na current in Xenopus oocytes. Eur. J. Physiol. 429:1995;825-831.
6. Challiss, R. A. J. Mass measurement of key phosphoinositide cycle intermediates. In: Kendall, D. A.; Hill, S. J., eds. Signal transduction protocols, vol. 41. Totowa, NJ: Humana Press; 167-176.
7. 2. Methods Enzymol. 197:1991;75-79.
8. Clemens J.A., Stephenson D.T., Smalstig E.B., Roberts E.F., Johnstone E.M., Sharp J.D., Little S.P., Kramer R.M. Reactive glial express cytosolic phospholipase A2 after transient global forebrain ischemis in the rat. Stroke. 27:1996;525-535.
9. Cooper D.M.F., Mons N., Karpen J.W. Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature. 374:1995;421-424.
10. Farooqui A.A., Horrocks L.A. Involvement of glutamate receptors, lipases and phospholipases in long term potentiation and neurodegeneration. J. Neurosci. Res. 38:1994;6-11.
11. 2 in neurodegeneration. Neurochem. Int. 30:1997;517-522.
12. Finegold D., Lattimer S.A., Nolle S., Bernstein M., Greene D.A. Polyol pathway activity and myo-inositol metabolism A suggested relationship in the pathogenesis of diabetic neuropathy . Diabetes. 32:1983;988-992.
13. +-ATPase in the pathogenesis of diabetic complications. N. Engl. J. Med. 316:1987;599-616.
14. Greene, D. A.; Sima, A. A. F.; Lattimer, S. A. Pathogenesis of diabetic neuropathy: Role of altered phosphoinositide metabolism. In: Nelson, J., ed. CRC critical reviews in neurobiology, vol. 5. Boca Raton, FL; 1989:143-219.
15. Greene D.A., Sima A.A.F., Pfeifer M.A., Alberts J.W. Diabetic neuropathy. Annu. Rev. Med. 41:1990;303-317.
16. Gusovsky F., Gutkind J.S. Selective effects of activation of protein kinase C isozymes on cAMP accumulation. Mol. Pharmacol. 39:1991;124-129.
17. +-ATPase activity in sciatic nerve of diabetic mice by administration of H7 or calphostin C inhibitors of protein kinase C. Diabetes. 42:1992;257-263.
18. Inoguchi T., Battan R., Handler E., Sportsman J.R., Heath W., King G.L. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats Differential reversibility to glycemic control by islet cell transplantation . Proc. Natl. Acad. Sci. USA. 89:1992;11059-11063.
19. Ishii H., Koya D., King G.L. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J. Mol. Med. 76:1998;21-31.
20. Kakiuchi S., Rall T.W. The influence of chemical agents on the accumulation of adenosine 3′,5′-phosphate in slices of rabbit cerebellum, studies on adenosine 3′,5′-phosphate rabbit cerebral cortex. Mol. Pharmacol. 4:1968;367-379.
21. Katada T., Gilman A.G., Watanabe Y., Bauer S., Jakobs K.H. Protein kinase C phosphorylates the inhibitory guanine nucleotide binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase. Eur. J. Biochem. 151:1985;431-437.
22. Kaur G., Sharma P., Bhardwaj S.K., Kaur G. GABA agonists and neurotransmitters metabolizing enzymes on steroid-primed OVX rats. Mol. Cell. Biochem. 167:1997;107-111.
23. Kennerly D.A., Parker C.W., Sullivan T.J. Use of diacylglycerol kinase to quantitate picomole levels of 1,2-diacylglycerol. Anal. Biochem. 98:1979;123-131.
24. Koya D., King G.L. Protein kinase C activation and the development of diabetic complications. Diabetes. 47:1998;859-866.
25. Lakhman S.S., Kaur G. Effect of experimental diabetes on monoamine oxidase activity from discrete areas of rat brain Relationship with diabetes associated reproductive failure . Mol. Cell. Biochem. 177:1997;15-20.
26. Longo F.M., Lebeau J., Gerrero M.R., Heckman H., Myers R.R. Delayed nerve regeneration in streptozotocin diabetic rats. Muscle Nerve. 9:1986;385-393.
27. +-ATPase by protein kinase C. Biochim. Biophys. Acta. 1052:1990;143-151.
28. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurements with folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
29. Mayer J.H., Tomlinson D.R. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or on aldose reductase inhibitor in streptozotocin diabetic rats. Diabetologia. 25:1983;433-438.
30. Meiri K.F., McLean W.G. Axonal transport of protein in motor fibres of experimentally diabetic rats - fast anterograde transport. Brain Res. 238:1982;77-88.
31. Natarajan V., Dyck P.J., Schmid H.H.O. Alterations of inositol lipid metabolism of rat sciatic nerve in streptozotocin-induced diabetes. J. Neurochem. 36:1981;413-419.
32. Partanen J., Niskanen L., Lehinen J., Mervaala E., Siitonen O., Uusitupa M. Natural history of peripheral neuropathy in patients with non insulin dependent diabetes mellitus. N. Engl. J. Med. 333:1995;89-94.
33. Pieroni J.P., Jacobowitz O., Chen J., Iyengar R. Signal recognization and interaction by Gs-stimulated adenylyl cyclase. Curr. Opin. Neurobiol. 3:1993;345-351.
34. Preiss J., Loomis C.R., Bishop W.R., Stein R., Niedel J.E., Bell R.M. Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes and ras and sis transformed normal rat kidney cells. J. Biol. Chem. 261:1986;8597-8600.
35. Raymond J.R., Olsen C.L. Protein kinase A induces phosphorylation of the human 5-HT 1A receptor and augments its desensitization by protein kinase C in CHO-K1 cells. Biochemistry. 33:1994;11264-11269.
36. Roberts R.E., McLean W.G. Protein kinase C isozyme expression in sciatic nerves and spinal cords of experimentally diabetic rats. Brain Res. 754:1997;147-156.
37. Roskoski R. Jr. Assay of protein kinases. Methods Enzymol. 99:1983;2-6.
38. Shimohama S., Fujimoto S., Taniguchi T., Kimura J. Phosphotidyl inositol specific phospholipase C activity in the post-mortem human brain No alteration in Alzheimer's disease . Brain Res. 579:1992;347-349.
39. Stevens M., Lattimer S.A., Feldman E., Sima A.A.F., Greene D.A. Correction of nerve conduction slowing nerve myo-inositol but not sorbitol by acetyl-L-carnitine in the streptozotocin diabetic rat (abstract). Diabetes. 44:(suppl. I):1995;12A.
40. Tang E.Y., Parker P.J., Beattie J., Houslay M.D. Diabetes induces selective alterations in the expression of protein kinase C isoforms in hepatocytes. FEBS Lett. 326:1993;117-123.
41. 2+ on vasopressin-mediated cyclic adenosine monophosphate formation cultured rat inner medullary collecting tubule cells. J. Clin. Invest. 77:1986;1574-1583.
42. Thomas P.K. Diabetic neuropathy Human and experimental . Drugs. 32:1986;36-42.
43. Whiting P.H., Palmano K.P., Howthorne J.N. Enzymes of myo-inositol and inositol lipid metabolism in rats with streptozotocin-induced diabetes. Biochem. J. 179:1979;549-553.
44. Wilkinson S.E., Hallam T.J. Protein kinase C Measurement of translocation, activation and role in cellular responses . Methods Mol. Biol. 41:1995;261-270.
45. Wolfe L.S., Horrocks L.A. Eicosanoids. Siegel G.J., Agranoff B.W., Albers R.W., Molinoff B.P. Basic neurochemistry. 1994;475-490 Raven Press, New York.
46. Yorek M.A., Dunlap J.A. The effect of elevated glucose levels on myo-inositol metabolism in cultured bovine aortic endothelial cells. Metabolism. 38:1989;16-22.
47. Zhang L., Yu Y., Mackin S., Weight F.F., Uhl G.R., Wang J.B. Differential μ-opiate receptors phosphorylation and desensitization induced by agonists and phorbol esters. J. Biol. Chem. 271:1996;11449-11454.
48. Zhu X., Eichberg J. 1,2-Diacylglycerol content and its arachidonyl-containing molecular species are reduced in sciatic nerve from streptozotocin-induced diabetic rats. J. Neurochem. 55:1990;1087-1090.